dexamethasone,lenalidomide,bortezomib
takeda
['determination']
also, patients less likely to complete pro assessments when they are very symptomatic, as shown in determination: 83% completed surveys at c5 of rvd alone versus only 59% after asct (when qol was worst). this is a major challenge and good implementation sci needed. #asco22 
Heme/onc fellow. #lymsm & #mmsm patient-reported outcomes researcher. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. ??????